Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$465M |
| 2 |
Microsoft
MSFT
|
+$373M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
ExxonMobil
XOM
|
+$253M |
| 5 |
Meta Platforms (Facebook)
META
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$249M |
| 2 |
STJ
St Jude Medical
STJ
|
+$203M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$156M |
| 4 |
HAR
Harman International Industries
HAR
|
+$71.2M |
| 5 |
CSC
Computer Sciences
CSC
|
+$56.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.77% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.31% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XRN
3526
Chiron Real Estate Inc
XRN
$475M
| $251K | ﹤0.01% |
5,546
+864
| +18% | +$37.3K |
|
3527
AB InBev
BUD
$164B
| $250K | ﹤0.01% |
2,284
-3,021
| -57% | -$325K |
|
3528
Galectin Therapeutics
GALT
$315M
| $250K | ﹤0.01% |
109,011
+774
| +0.7% | +$1.17K |
|
3529
NLI Holdings
NL
$308M
| $250K | ﹤0.01% |
38,884
+2,017
| +5% | +$13.6K |
|
|
AMPE
3530
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $250K | ﹤0.01% |
1,044
+28
| +3% | +$7.53K |
|
3531
Canadian Natural Resources
CNQ
$97.4B
| $249K | ﹤0.01% |
15,509
-282
| -2% | -$4.27K |
|
3532
vTv Therapeutics
VTVT
$135M
| $248K | ﹤0.01% |
949
+16
| +2% | +$3.65K |
|
|
SPRT
3533
DELISTED
support.com, Inc.
SPRT
| $248K | ﹤0.01% |
113,070
+8,969
| +9% | +$20.1K |
|
|
CIVI
3534
DELISTED
Civitas Resources
CIVI
| $247K | ﹤0.01% |
1,912
| – | – |
|
3535
EyePoint Inc
EYPT
$1.13B
| $246K | ﹤0.01% |
14,305
+76
| +0.5% | +$1.35K |
|
3536
Spyre Therapeutics
SYRE
$9.29B
| $246K | ﹤0.01% |
1,326
+394
| +42% | +$55.6K |
|
3537
Equinor
EQNR
$97.4B
| $245K | ﹤0.01% |
14,300
-372
| -3% | -$6.68K |
|
3538
Sumitomo Mitsui Financial
SMFG
$161B
| $245K | ﹤0.01% |
33,831
+6,217
| +23% | +$48.3K |
|
|
MRUS
3539
DELISTED
Merus
MRUS
| $244K | ﹤0.01% |
+10,035
| New | +$256K |
|
|
LUX
3540
DELISTED
Luxottica Group
LUX
| $244K | ﹤0.01% |
4,450
+466
| +12% | +$24.9K |
|
3541
XWELL
XWEL
$8.06M
| $243K | ﹤0.01% |
93
| – | – |
|
3542
Live Ventures
LIVE
$30.7M
| $241K | ﹤0.01% |
15,164
+44
| +0.3% | +$777 |
|
|
UFAB
3543
DELISTED
Unique Fabricating, Inc.
UFAB
| $240K | ﹤0.01% |
19,963
+330
| +2% | +$4.04K |
|
|
SITO
3544
DELISTED
SITO MOBILE, LTD
SITO
| $240K | ﹤0.01% |
93,580
| – | – |
|
|
VBFC
3545
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $239K | ﹤0.01% |
8,883
| – | – |
|
|
BLVD
3546
DELISTED
Boulevard Acquisition Corp. II Class A Common Stock
BLVD
| $238K | ﹤0.01% |
+23,845
| New | +$238K |
|
3547
Ceragon Networks
CRNT
$192M
| $237K | ﹤0.01% |
72,843
-35,302
| -33% | -$125K |
|
3548
Enterprise Products Partners
EPD
$82.2B
| $237K | ﹤0.01% |
8,610
| – | – |
|
|
REXX
3549
DELISTED
Rex Energy Corporation
REXX
| $236K | ﹤0.01% |
50,461
+18,391
| +57% | +$111K |
|
3550
BBVA Argentina
BBAR
$3.53B
| $235K | ﹤0.01% |
12,775
-38,510
| -75% | -$700K |
|
Similar funds
Geode Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Geode Capital Management held 4,180 positions worth $244B, up 13% from $215B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management deployed $16.9B of net new capital in Q1 2017, opening 139 new positions and adding to 3,365 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Computer Sciences, an estimated $56.7M trimmed.
- Geode Capital Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
- Geode Capital Management added most to Apple in Q1 2017, an estimated $465M increase.
- Geode Capital Management's biggest Q1 2017 reduction was Computer Sciences, cutting an estimated $56.7M.
- Geode Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $249M.
- Geode Capital Management's ten largest holdings make up 16% of its $244B portfolio in Q1 2017.
- Geode Capital Management opened 139 new positions and closed 111 in Q1 2017.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.